Search

Home > Industry Focus > Healthcare: Is Zolgensma's $2.1 Million Price Tag Ridiculous?
Podcast: Industry Focus
Episode:

Healthcare: Is Zolgensma's $2.1 Million Price Tag Ridiculous?
Category: Business
Duration: 00:23:14
Publish Date: 2019-05-29 14:30:00
Description: Here's why paying $2 million for Novartis' revolutionary gene therapy for SMA may not be as crazy as it sounds.  Also, why shares slumped after BioMarin reported its gene therapy may virtually eliminate bleeding in hemophilia A patients.

Check out more of our content here:
Total Play: 0

Users also like

0 Episodes
MarketFooler .. 100+     6
700+ Episodes
Rule Breaker .. 200+     6
2K+ Episodes
Motley Fool .. 300+     10+

Some more Podcasts by The Motley Fool

300+ Episodes
Motley Fool ..    
700+ Episodes
Rule Breaker .. 200+     6
400+ Episodes
Motley Fool .. 100+     5
2K+ Episodes
Motley Fool .. 300+     10+
2K+ Episodes
Motley Fool ..